Recombinant multi-species CNOT7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CNOT7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene binds to an anti-proliferative protein, B-cell translocation protein 1, which negatively regulates cell proliferation. Binding of the two proteins, which is driven by phosphorylation of the anti-proliferative protein, causes signaling events in cell division that lead to changes in cell proliferation associated with cell-cell contact. The encoded protein downregulates the innate immune response and therefore provides a therapeutic target for enhancing its antimicrobial activity against foreign agents. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and X. [provided by RefSeq, Apr 2016]
The Alternative Names of target: BTG1-binding factor 1,CAF-1,CAF1,CCR4-NOT transcription complex subunit 7,CCR4-associated factor 1 (CAF-1),CNOT7,Caf1,Caf1a,Cnot7,Pop2,hCAF-1

Target products collectionGo to CNOT7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7842-Ag-1/ GM-Tg-hg-IP7842-Ag-2 Human CNOT7 protein Human
GM-Tg-rg-IP7842-Ag-1/ GM-Tg-rg-IP7842-Ag-2 Rat CNOT7 protein Rat
GM-Tg-mg-IP7842-Ag-1/ GM-Tg-mg-IP7842-Ag-2 Mouse CNOT7 protein Mouse
GM-Tg-cynog-IP7842-Ag-1/ GM-Tg-cynog-IP7842-Ag-2 Cynomolgus/Rhesus macaque CNOT7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7842-Ag-1/ GM-Tg-felg-IP7842-Ag-2 Feline CNOT7 protein Feline
GM-Tg-cang-IP7842-Ag-1/ GM-Tg-cang-IP7842-Ag-2 Canine CNOT7 protein Canine
GM-Tg-bovg-IP7842-Ag-1/ GM-Tg-bovg-IP7842-Ag-2 Bovine CNOT7 protein Bovine
GM-Tg-equg-IP7842-Ag-1/ GM-Tg-equg-IP7842-Ag-2 Equine CNOT7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7842-Ag-1/ GM-Tg-hg-IP7842-Ag-2; GM-Tg-rg-IP7842-Ag-1/ GM-Tg-rg-IP7842-Ag-2;
GM-Tg-mg-IP7842-Ag-1/ GM-Tg-mg-IP7842-Ag-2; GM-Tg-cynog-IP7842-Ag-1/ GM-Tg-cynog-IP7842-Ag-2;
GM-Tg-felg-IP7842-Ag-1/ GM-Tg-felg-IP7842-Ag-2; GM-Tg-cang-IP7842-Ag-1/ GM-Tg-cang-IP7842-Ag-2;
GM-Tg-bovg-IP7842-Ag-1/ GM-Tg-bovg-IP7842-Ag-2; GM-Tg-equg-IP7842-Ag-1/ GM-Tg-equg-IP7842-Ag-2
Products Name CNOT7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CNOT7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CNOT7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.